Objective: Extracorporeal shock wave lithotripsy (ESWL) of urinary stones is a well-established treatment modality applied to adult patients. We report on the technique, complications, and long-term results of ESWL in pediatric patients. Methods: Between 1987 and 1994, 27 children with stones distributed throughout the urinary tract were treated with ESWL. The treatments were performed either under general anesthesia or intravenous sedation. No complications occurred secondary to the treatments. A total of 34 ESWL sessions were performed with an average of 2,165 shocks per patient and a mean energy of 22.3 kV. Results: Minor early complications, such as fever, pain, and hydronephrosis, were seen in 7 patients. The overall stone-free rate was 92%. No late complications, such as renal insufficiency, pulmonary dysplasia, or skeletal deformation, were detected during a mean follow-up period of 46 months. Conclusion: ESWL is a safe and reliable treatment even in the pediatric patient.

Keywords:
Urolithiasis, children, Extracorporeal shock wave lithotripsy, complications, Long-term results, extracorporeal shock wave lithotripsy
This content is only available via PDF.
© 1996 S. Karger AG, Basel
1996
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.